Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000010

Chief Discovery Officer sold 36,284 shares at an average $37.09 ($1,345,894)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kreitzer Anatol · Chief Discovery Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-15 Sale : show line 1 in the form 10b5-1 −5,545 $36.13 $200,341 205,645 D
2026-07-15 Sale : show line 2 in the form 10b5-1 −4,510 $36.94 $166,599 201,135 D
2026-07-16 Sale : show line 3 in the form 10b5-1 −7,464 $36.66 $273,630 193,671 D
2026-07-16 Sale : show line 4 in the form 10b5-1 −1,592 $37.44 $59,604 192,079 D
2026-07-17 Sale : show line 5 in the form 10b5-1 −2,833 $37.05 $104,963 189,246 D
2026-07-17 Sale : show line 6 in the form 10b5-1 −14,140 $37.70 $533,078 175,106 D
2026-07-17 Sale : show line 7 in the form 10b5-1 −200 $38.39 $7,678 174,906 D
Open-market sales · 36,284 sh · avg $37.09 · $1,345,894
Loading xslF345X06/form4-07202026_060701.xml…